135 related articles for article (PubMed ID: 8691914)
1. [Drug surveillance within the pharmaceutical industry: present and future].
Soto J; Sacristán JA; Alsar MJ; Galende I
Med Clin (Barc); 1996 May; 106(17):665-9. PubMed ID: 8691914
[No Abstract] [Full Text] [Related]
2. Strategy for surveillance of adverse drug events.
Bright RA
Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
[No Abstract] [Full Text] [Related]
3. An underrecognized challenge in evaluating postmarketing drug safety.
Roden DM
Circulation; 2005 Jan; 111(3):246-8. PubMed ID: 15668350
[No Abstract] [Full Text] [Related]
4. [Drug surveillance: concepts, objectives, and methods].
Susano RC; Laborinho Fialho L; de Quirós JF
Acta Med Port; 1992 Dec; 5(11):595-602. PubMed ID: 1293954
[TBL] [Abstract][Full Text] [Related]
5. European pharmacovigilance: an overview of pharmacovigilance inspections.
Koster MC; van den Oetelaar AH
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):711-3. PubMed ID: 16142691
[No Abstract] [Full Text] [Related]
6. European pharmacovigilance legislation: has it led to implementation of pharmacovigilance inspections?
Bleumink GS; in't Veld BA; Stricker BH
Pharmacoepidemiol Drug Saf; 2001; 10(4):339-40. PubMed ID: 11760496
[No Abstract] [Full Text] [Related]
7. Regulatory agencies, pharmaceutical information and the Internet: a European perspective.
Bauschke R
Health Policy; 2012 Jan; 104(1):12-8. PubMed ID: 22101089
[TBL] [Abstract][Full Text] [Related]
8. [Post-marketing surveillance].
Offerhaus L
Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1201; author reply 1202. PubMed ID: 8692358
[No Abstract] [Full Text] [Related]
9. FDA attempting to overcome major roadblocks in monitoring drug safety.
Zielinski SL
J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
[No Abstract] [Full Text] [Related]
10. Adverse drug reaction monitoring in pediatric practice.
Kshirsagar NA; Karande S
Indian Pediatr; 1996 Dec; 33(12):993-8. PubMed ID: 9141798
[No Abstract] [Full Text] [Related]
11. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
Fleuranceau-Morel P
Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
[TBL] [Abstract][Full Text] [Related]
12. [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].
Aguirre C; Haramburu F
Therapie; 1995; 50(6):563-9. PubMed ID: 8745957
[TBL] [Abstract][Full Text] [Related]
13. The US drug safety system: role of the pharmaceutical industry.
Gibson BR; Suh R; Tilson H
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):110-4. PubMed ID: 17724741
[TBL] [Abstract][Full Text] [Related]
14. The drug safety system conundrum.
Tiedt TN
Food Drug Law J; 2007; 62(3):547-558. PubMed ID: 17915396
[No Abstract] [Full Text] [Related]
15. Re-examining our approach to the approval and use of new drugs.
Lee SK
CMAJ; 2006 Jun; 174(13):1855. PubMed ID: 16785460
[No Abstract] [Full Text] [Related]
16. [The Medical Products Agency is responsible for the control of medical technological products: we need more active medical professionals reporting shortages].
Philipson L
Lakartidningen; 2008 Mar 5-11; 105(10):746-7. PubMed ID: 18422241
[No Abstract] [Full Text] [Related]
17. Decision support methods for the detection of adverse events in post-marketing data.
Hauben M; Bate A
Drug Discov Today; 2009 Apr; 14(7-8):343-57. PubMed ID: 19187799
[TBL] [Abstract][Full Text] [Related]
18. [The need for 'postmarketing surveillance'].
Stricker BH; in 't Veld BA; Feenstra J
Ned Tijdschr Geneeskd; 1999 Apr; 143(14):711-3. PubMed ID: 10347624
[TBL] [Abstract][Full Text] [Related]
19. Global harmonization is not all that global: divergent approaches in drug safety.
Castle GH; Kelly B
Food Drug Law J; 2008; 63(3):601-22. PubMed ID: 19031662
[No Abstract] [Full Text] [Related]
20. Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance.
Jacobson JD; Feigal D
Food Drug Law J; 2007; 62(3):529-46. PubMed ID: 17915395
[No Abstract] [Full Text] [Related]
[Next] [New Search]